Latest stories on DYAI
Dyadic International files to sell 3.625M shares of common stock for holders
The Fly28 · bearishgeneral
Imperium AI CEO Shazir Mucklai Sees Comeback Potential in Dyadic (NASDAQ: DYAI), Calls Board Meeting
Business Insider56 · neutralgeneral
Dyadic International (Nasdaq: DYAI) Advances Next-Generation Biomanufacturing with Global Health Support
Business Insider63 · neutralproduct/pr
Dyadic International (DYAI) Q2 2026 Earnings Call Transcript
Yahoo Top63 · neutralearnings
Dyadic International (DYAI) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Dyadic International prices 3.625M shares at 79.5c in registered direct offering
The Fly28 · bearishgeneral
Dyadic International Announces New Equity Financing Agreements
TipRanks28 · bearishgeneral
DYADIC INTERNATIONAL INC (DYAI) files 8-K
SEC 8-K50 · neutralgeneral
Dyadic International secures $2.9M via registered direct offering and concurrent warrant private placement
Seeking Alpha28 · bearishgeneral
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement
GlobeNewswire28 · bearishgeneral
Dyadic signals 40% transferrin cost reduction as it pursues non-dilutive capital amid going concern disclosure
Seeking Alpha53 · neutralgeneral
Dyadic International, Inc. (DYAI) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Dyadic International GAAP EPS of -$0.06 misses by $0.03, revenue of $0.96M misses by $0.67M
Seeking Alpha34 · bearishearnings
DYADIC INTERNATIONAL INC (DYAI) files 8-K
SEC 8-K50 · neutralgeneral
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
GlobeNewswire63 · neutralearnings
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
Business Insider63 · neutralearnings
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
Business Insider63 · neutralproduct/pr
Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026
Business Insider50 · neutralearnings
Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
Business Insider67 · bullishproduct/pr
Dyadic regains compliance with Nasdaq listing requirements
Seeking Alpha63 · neutralgeneral
Dyadic Regains Nasdaq Compliance, Secures Continued Listing
TipRanks59 · neutralgeneral
DYADIC INTERNATIONAL INC (DYAI) files 8-K
SEC 8-K50 · neutralgeneral
Dyadic Announces Continued Listing on the Nasdaq Capital Market
StockTitan50 · neutralgeneral
Dyadic Announces Continued Listing on the Nasdaq Capital Market
Business Insider50 · neutralgeneral
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program | DYAI Stock News
StockTitan63 · neutralproduct/pr